L26/P-598 Patient Reported Experiences with Natural-Cycle Versus Artificial-Cycle Frozen Embryo Transfer: A Secondary Outcome Analysis of a Randomized Controlled Trial
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.928 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von E. Dancet und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does transferring embryos in a natural-cycle result in better patient-experiences as compared to transferring embryos in an artificial cycle? Summary answer Natural cycle frozen embryo transfer results in better patient experiences regarding treatment tolerability and treatment-induced problems as compared to artificial cycle frozen embryo transfer. What is known already Frozen embryos can be transferred in natural cycles or artificial cycles, requiring sequential estrogen and progesterone administration. These regimes proved not to differ in efficacy (i.e. pregnancy rates) but concerns about the obstetric risks of artificial-cycle Frozen Embryo Transfers (FETs) have emerged, and natural-cycle-FETs require more monitoring visits in return for less hormonal medication. Whether either of both regimes is experienced more positively by women had yet to be examined. This should ideally be studied with a reliable patient reported experiences measure (PREM) in randomized women not yet aware of their pregnancy status, as the latter proved to influence PREMs. Study design, size, duration This abstract reports on the analysis of two secondary outcomes of a multicenter, open-label trial randomizing 554 women between Natural-cycle-FET and artificial-cycle-FET (2018-2024). Two Patient Reported Experience Measures (PREMs) were disseminated on the day of embryo transfer and returned before the pregnancy test at the clinic. Women who had performed a pregnancy test at home or had vaginal bleeding were excluded before the analysis. Participants/materials, setting, methods Eligible women with a regular ovulatory cycle and normal uterine cavity experienced the transfer of a frozen day-3 embryo or blastocyst in one of five recruiting fertility clinics. The ‘Treatment Tolerability’ PREM of FertiQol-questionnaire (0-100; the higher, the better) and ‘treatment-induced problems’ PREM of the ‘Difficulties-with Infertility-and-Treatment-questionnaire’ (0-5; the lower, the better) assessed experiences with treatment. Other subscales of these questionnaires were considered less relevant as they assessed care experiences or wellbeing outcomes. Main results and the role of chance A total of 373 randomized women returned the PREMs (67% response rate) and 245 of them indicated to be unaware of their pregnancy status. The eligible women randomized to natural-cycle-FET (n = 124) and artificial-cycle-FET (n = 121) did not differ in background. The women were on average 33.5 years of age, had been infertile for on average 2.5 years and the studied transfer was most commonly part of their first IVF-cycle. Women randomized to natural-cycle-FET indeed had more monitoring visits (median=3; IQR=2-4) as compared to women randomized to artificial-cycle-FET (n = 121; median=2; IQR=2-3; p = 0.005). The reliability of both PREMs was confirmed, with Cronbach alpha statistics >0.60 and Item-total-correlations >0.40. The FertiQol-Treatment-Tolerability PREM detected a difference in patient experiences with treatment in favor of natural-cycle-FET (75.7±14.5 vs. 70.9± 16.0; p = 0.018; Cohen’s d effect size=0.32). Moreover, natural-cycle-FET resulted in less ‘treatment-induced problems’ assessed with the Difficulties-with-Infertility-and-its-Treatment-questionnaire as compared to artificial-cycle-FET (3.2±1.5 vs. 3.6±1.5; p = 0.003; Cohen’s d effect size=0.26). Limitations, reasons for caution This is a secondary analysis of a trial primarily designed to examine differences in clinical pregnancy rates. The identified differences remain significant after Bonferroni correction for multiple (n = 2) testing. Regarding the clinical relevance of the differences, small – medium effect sizes were identified for both PREMs. Wider implications of the findings Women and clinic staff sharing treatment decisions should be informed that natural-cycle-FET is superior to artificial-cycle-FET regarding treatment experiences besides safety considerations, whilst pregnancy rates do not differ. Including psychosocial outcomes in RCTs is crucial to allow fully informing women on all important treatment characteristics prior to shared decision-making. Trial registration number Yes
Zitieren
APA
Dancet, E., Geysenbergh, B., Vriens, J., Reynders, M., Debrock, S., Lie-Fong, S., Vanhie, A., Tomassetti, C., Bafort, C., Meeuwis, L., Neyens, S., Pelckmans, S., Loecker, P. D., & Peeraer, K. (2026). L26/P-598 Patient Reported Experiences with Natural-Cycle Versus Artificial-Cycle Frozen Embryo Transfer: A Secondary Outcome Analysis of a Randomized Controlled Trial. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.928
Vancouver
Dancet E, Geysenbergh B, Vriens J, Reynders M, Debrock S, Lie-Fong S, et al. L26/P-598 Patient Reported Experiences with Natural-Cycle Versus Artificial-Cycle Frozen Embryo Transfer: A Secondary Outcome Analysis of a Randomized Controlled Trial. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.928
BibTeX
@article{Dancet2026,
author = {Dancet, E. and Geysenbergh, B. and Vriens, J. and Reynders, M. and Debrock, S. and Lie-Fong, S. and Vanhie, A. and Tomassetti, C. and Bafort, C. and Meeuwis, L. and Neyens, S. and Pelckmans, S. and Loecker, P. De and Peeraer, K.},
title = {L26/P-598 Patient Reported Experiences with Natural-Cycle Versus Artificial-Cycle Frozen Embryo Transfer: A Secondary Outcome Analysis of a Randomized Controlled Trial},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.928}
}
EUVIMED